97
Participants
Start Date
July 30, 2008
Primary Completion Date
September 15, 2009
Study Completion Date
September 19, 2018
AZD2281
400mg Oral twice daily
Liposomal Doxorubicin
50mg/m2 Monthly Intravenous
AZD2281
200mg oral twice daily
Research Site, Randwick
Research Site, Leuven
Research Site, East Melbourne
Research Site, New York
Research Site, Lund
Research Site, Haifa
Research Site, Boca Raton
Research Site, Cologne
Research Site, Ramat Gan
Research Site, Houston
Research Site, München
Research Site, Los Angeles
Research Site, San Francisco
Research Site, Tel Aviv
Research Site, Boston
Research Site, Melbourne, Parkville
Research Site, Szczecin
Research Site, Barcelona
Research Site, Hospitalet deLlobregat
Research Site, Cambridge
Research Site, Edinburgh
Research Site, London
Research Site, Manchester
Research Site, Sutton
Lead Sponsor
AstraZeneca
INDUSTRY